Stay updated on Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Sign up to get notified when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.

Latest updates to the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedCore content updated with a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference3%
- Check24 days agoChange DetectedUpdated to Revision: v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while keeping the revision label as the primary addition.SummaryDifference0.4%
- Check39 days agoChange DetectedThe page now shows Revision: v3.0.2 instead of v3.0.1; the 'Back to Top' link has been removed as a minor UI change.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check53 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new topics related to drug safety and health conditions, while removing several location-related terms and disease classifications.SummaryDifference3%
- Check67 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.